JADAK’s Post

BodiMetrics Circul VS is entering the world of Nocturnal Medicine. We will be doing clinical research in many areas of medicine with this new technology of Continuous Blood Oxygen and Continuous Blood Pressure

Meet our experts at the @SMI 2024 in London and learn more about the future of Soft Mist Inhalers!

Our colleagues Luís Carraça and Chinaniso Majoni are currently attending the MedTech Europe Forum 2024 in Vienna. Luis said: "It's been really interesting listening on this first day to a lot of talk about innovation, namely relating to how new MedTech can be made accessible to patients safely and the impact of different regional regulations on where industry decides to launch new devices. Also environmental and financial sustainability and how these impact on MedTech innovation remains a hot topic too, along with localisation discussions about supply chains." #MedTech #GMDN

At the Strategic Innovation Gateway event today… Significant innovations in a vital area. Setting out the creation of national centre of excellence. #rehabtechnologiesnetwork #medilink #healthtech #medicaldevicedesign #DefenceMedicalRehabilitatioCentre #DMRC #industrialdesign #Sportsinnovation #rehabtechnology #regenerativemedine #revolutionisingrehab #smarttextiles #etc

See you next week at #HIMSS24!  Make sure to stop by booth 981 to learn more about innovating with #DataAnalytics to succeed at #valuebasedcare and how Milliman MedInsight is empowering #healthcare organizations with the tools they need to stay ahead of the curve. Our team of experts is excited to chat with you about driving transformation with #TrustedData and #PowerfulInsights.  Schedule a meeting below or stop by the booth to see the power of our products, and the revolution that Milliman MedInsight can bring to your organization.  See you there!  #HIMSS2024 #HealthcareTransformation #ActuarialHealth 

MedTech Innovator just released the Mid-Stage Grand Finalist and Value Award Finalists! I want to first congratulate ALL the companies that have participated in the program over the past several months. Recognition like this is a celebration of the accomplishments of over 90 companies in this year's cohort. For this post related to the "Value Award", I'd like to recognize Allen Waziri of iCE Neurosystems, Inc., who was also part of the American Heart Association #CHTI accelerator track in partnership with MedTech Innovator. Allen, is a clinician who recognized the need that #EEG data is severely underutilized, reported 3% utilization versus the guideline recommended 100% of the time. In this case, I think the use of "award" represents recognizing an amazing individual that devoted his professional career, as an interventional neuro surgeon, to the care of patients, and then took it a step further when he saw he could create a new method to bring a routine care procedure, that is often under performed into mainstream care; due to time, cost, and personnel constraints. Allen accomplished this without a background as an entrepreneur and persevered with courage in the face of many, many challenges. This "value award" is measured by value proposition, patient benefit, health economic impact and other factors. The finals will be at the MedTech Strategist conference this month in San Diego, CA. All companies in the MTI program participate in this process and deem it one of the most valuable (no pun) takeaways from the program. This is one story of many stories in the MedTech Innovator program, of founders that accomplish amazing things to advance patient care. It would be just as easy to write about all companies in this release, as well as all companies in the cohort I have had the honor of working with. It is like having kids, I don't love one of you more than another, and you all shine at different times in different ways. I'd like to thank the American Heart Association, the #CHTI program, Jeffrey Makowka, Mitchell Elkind, and all the wonderful people that made this experience possible for companies in the AHA cohort. Special recognition also to Brian Benson and Nicole Black, PhD from MedTech Innovator. Their efforts in particular to make this award recognition possible.

Meet me and my colleague Wida Gurbanian for the next Swiss MedTech Day ⛷ 𝗡𝗮𝘃𝗶𝗴𝗮𝘁𝗶𝗻𝗴 𝗚𝗹𝗼𝗯𝗮𝗹 𝗜𝗺𝗽𝗮𝗰𝘁 💡 𝗜𝗻𝗻𝗼𝘃𝗮𝘁𝗶𝘃𝗲 𝗥𝗲𝘀𝗽𝗼𝗻𝘀𝗲𝘀 🌍 𝗦𝘂𝘀𝘁𝗮𝗶𝗻𝗮𝗯𝗹𝗲 𝗦𝗼𝗹𝘂𝘁𝗶𝗼𝗻𝘀 ☄ 𝗘𝗺𝗯𝗿𝗮𝗰𝗶𝗻𝗴 𝗖𝗼𝗺𝗽𝗹𝗲𝘅𝗶𝘁𝘆 Key Topics to be discussed - looking forward to our meet & greet #swissmedtechday #tüvsüd #productlifecycle #complexity

We're looking forward to #MTC24 in Toronto Oct. 15-17! Here's a little intro to our mission and our technology: Rna Diagnostics Inc. is a clinical stage molecular diagnostics company for personalized cancer therapy management. Our predictive biomarker platform technology, Veridapt DX™, measures early solid tumor response to neoadjuvant cancer treatment. Veridapt DX identifies non-responsive solid tumors by monitoring the degree of RNA (rRNA) disruption in the cells. Once validated, it will enable physicians to escalate or de-escalate therapy, or select an alternative strategy, as early as 5 weeks into a standard 6-month treatment regimen. Veridapt DX is now entering Phase 2 clinical trial in 7 countries. Get in touch to meet up with our CEO John Connolly at The MedTech Conference to learn more. You can also read about our technology here: https://lnkd.in/d9x5RvVt #medtech #innovation #personalizedmedicine #precisionmedicine #oncology

AI4MDR and Tech Tour Growth/Health, Lausanne This year I was the moderator of the spit-fire session, highlighting the jungle of AI regulations in #Healthtech. A topic that we focus on at ETH Zürich and at Regulatory Thinking®. Starting with next Tuesday my collegue Niko Mangold an myself will share for you some smart #AI Tools, helping you to navigate regulations with assistance. #AI4MDR #RegulatoryThinking #dTIP Curious about this? Check it out NEXT TUESDAY: We will start a small series on #AI4MDR, #Tools, #Videos, #Webinars, #TemplateDocuments, #AI_Strategies … we want you to be successfull with your Business - but I have noticed so many cool products failing… See you soon!